Monthly Archives - November 2020

Teresa Whalen talks about CytoAgents and the treatment of Cytokine Storm

Teresa Whalen is the CEO of CytoAgents, a startup focused on the development of solutions to combat persistent and potentially deadly strains of Influenza, COVID19, and other viruses. Teresa’s career spans 20 years in the healthcare industry, including health technology executive, life sciences investor, and clinical pharmacist. She has brought multiple successful life-changing healthcare products to market. Read more >>
Read more...

ZetrOZ Systems is Selected Among the Most Innovative Healthcare Companies in 2020

ZetrOZ Systems, developers of the SAM family of ultrasound products, FDA-cleared bio regenerative medical devices supported with over 30 clinical efficacy studies, is proud to be recognized as one of the most innovative companies in healthcare, announcing its inclusion into the 2020 Inaugural List of Most Innovative Companies in Healthcare. The 2020 listing of Most Innovative companies in healthcare includes 60 companies from 30 different categories of innovation within the medical industry. Read more >>
Read more...

What Happens When Student Loan Payment Deferral Ends?

The Coronavirus Aid, Relief and Economic Security (CARES) Act included two provisions that were critical to helping Americans with student loan debt. One allowed borrowers to suspend payments through September 30, and that relief was later extended to December 31. Laurel Taylor, founder and CEO of FutureFuel.io, a company that supports student loan borrowers, explains that the payment suspension in the CARES Act allowed anyone who had a federal student loan to get a reprieve. Borrowers could pause their payments...
Read more...

Cognoptix Announces New Scientific Advisory Board with Alzheimer’s Research Leaders

Cognoptix, a leading diagnostics company dedicated to early detection of Alzheimer's disease (AD), announced today the formation of its new Scientific Advisory Board (SAB) with appointment of five world-class scientists and clinical researchers in AD. The SAB includes Jeffrey L. Cummings, MD, ScD; Lee E. Goldstein, MD, PhD; Philip Scheltens, MD, PhD; Martin R. Farlow, MD; and Carl H. Sadowsky, MD. Drs. Cummings and Goldstein will serve as SAB Clinical and Science Chairs, respectively. Read more...
Read more...

YSIF December 10th: How to Raise Angel Capital

Panel featuring Ziad Moukheiber, President and CEO of Boston Harbor Angels. TOPIC: How to Raise Angel Capital HOST: Dr. James Boyle, Exec. Director of Venture Development, OCR MODERATOR: Kristin King, MBA, VP of Corporate Development & Strategy: Defibtech PRESENTERS/AGENDA: • Ziad H. Moukheiber: President and CEO, Boston Harbor Angels Inc. • Anthony Gellert: Founder, Livingston Ventures Learn more >>
Read more...

Utah State Board of Education Announces Statewide Access to Scrible to Support Schools with Research and Writing Amid Distance Learning

The Utah State Board of Education (USBE) announces a statewide partnership with Scrible, a modern research and writing platform that supports distance learning. The partnership ensures that every Utah school district has access to Scrible Edu Pro, bringing the company's full suite of online research and writing tools to more than 665,000 students, teachers and librarians in grades K-12 for the current 2020-21 school year. Read more >>
Read more...

Aircuity Introduces “Air Quality as a Service” Solution to Accelerate Safer Building Re-openings

Aircuity, the leading provider of measurably better environments, today introduced "Air Quality as a Service" (AQaaS), a new indoor air quality (IAQ) solution that helps building owners create "healthy buildings" that meet both COVID-19 re-entry and longer term air quality requirements. As an operating expenditure, Aircuity's AQaaS requires no or low upfront capital, making it easier – and faster – to deploy in existing buildings. Read more >>
Read more...

SAM by ZetrOZ is the New, Go-To, Cost-Effective Treatment for Knee Arthritis Pain

ZetrOZ Systems, developers of Sustained Acoustic Medicine (SAM), a wearable, home-use, FDA-cleared bio regenerative medical device, announces that its product has been recognized as a cost-effective treatment for patients suffering from knee pain relating to arthritis in a recent research study published in the Journal of Orthopaedic Surgery and Research. Read more >>
Read more...

Esight launches wearable smart assistive device for the visually impaired in Europe

Esight Corp. is starting distribution of its newest low-vision assistive technology in France, Germany and the U.K. The latest version of the technology, the Esight 4, was designed to be more versatile and mobile than before, has double the display brightness and has improved the auto-focus function, according to the company. Read more >>
Read more...